UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma

PloS one, 2010-08, Vol.5 (8), p.e12419-e12419

2010

Link zum Volltext

Verfügbarkeit prüfen

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

The American journal of gastroenterology, 1999-09, Vol.94 (9), p.2467-2474

1999

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Feeling better about NASH

Alimentary pharmacology & therapeutics, 2023-08, Vol.58 (4), p.482-483

Di Bisceglie, Adrian M

2023

Link zum Volltext

Verfügbarkeit prüfen

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.115-126

2017

Link zum Volltext

Verfügbarkeit prüfen

Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial

The American journal of gastroenterology, 2023-07, Vol.118 (7), p.1226-1236

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia

Lipids in health and disease, 2020-11, Vol.19 (1), p.1-10, Article 239

2020

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis

The American journal of gastroenterology, 2022-11, Vol.117 (11), p.1805-1815

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components

PloS one, 2014-07, Vol.9 (7), p.e101422-e101422

2014

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy

BMC infectious diseases, 2020-08, Vol.20 (1), p.1-632, Article 632

2020

Link zum Volltext

Verfügbarkeit prüfen

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients

PloS one, 2010-02, Vol.5 (2), p.e9032

2010

Link zum Volltext

Verfügbarkeit prüfen

A novel target enrichment strategy in next-generation sequencing through 7-deaza-dGTP-resistant enzymatic digestion

BMC research notes, 2020-09, Vol.13 (1), p.445-445, Article 445

2020

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B

The American journal of gastroenterology, 2023-07, Vol.118 (7), p.1214-1225

2023

Link zum Volltext

Verfügbarkeit prüfen

Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals

Journal of general internal medicine : JGIM, 2020-04, Vol.35 (4), p.1011-1020

2020

Link zum Volltext

Verfügbarkeit prüfen

High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy

PloS one, 2014-06, Vol.9 (6), p.e100131

2014

Link zum Volltext

Verfügbarkeit prüfen

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection

PloS one, 2013-06, Vol.8 (6), p.e64992-e64992

2013

Link zum Volltext

Verfügbarkeit prüfen

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2010-04, Vol.31 (7), p.719-734

2010

Link zum Volltext

Verfügbarkeit prüfen

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.1001-1011

2018

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Hepatocellular Carcinoma Resulting From Hepatitis B: Are We There Yet?

Clinical gastroenterology and hepatology, 2014-05, Vol.12 (5), p.894-896

Di Bisceglie, Adrian M., MD, FACP

2014

Link zum Volltext

Verfügbarkeit prüfen

A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus

Clinical gastroenterology and hepatology, 2010-03, Vol.8 (3), p.280-288.e1

2010

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status

The American journal of gastroenterology, 2003-09, Vol.98 (9), p.2060-2063

2003

Link zum Volltext

Verfügbarkeit prüfen

Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis

Hepatology (Baltimore, Md.), 1991-12, Vol.14 (6), p.969-974

1991

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

Vaccine, 2010-08, Vol.28 (38), p.6367-6373

2010

Link zum Volltext

Verfügbarkeit prüfen

Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial

Clinical gastroenterology and hepatology, 2010-10, Vol.8 (10), p.877-883

2010

Link zum Volltext

Verfügbarkeit prüfen

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients

Oncology reports, 2006-07, Vol.16 (1), p.133-140

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 135

Suche als RSS-Feed

Aktive Filter

KollektionIEEE Xplore Digital Library

Zeitschrift / SerieGastroenterology

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(134)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

Editorial: Feeling better about NASH

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study

Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia

A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis

Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components

Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients

A novel target enrichment strategy in next-generation sequencing through 7-deaza-dGTP-resistant enzymatic digestion

Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B

Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals

High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy

Prevention of Hepatocellular Carcinoma Resulting From Hepatitis B: Are We There Yet?

A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus

Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status

Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients

Aktive Filter

Suchergebnisse filtern